GXO Logistics (GXO) Q4 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2024 earnings summary
15 Dec, 2025Executive summary
Achieved record revenue and adjusted EBITDA for both Q4 and full year 2024, with organic growth accelerating each quarter and adjusted EBITDA up 30% year over year in Q4.
Secured over $1 billion in new business wins for the second consecutive year, including a landmark $2.5 billion healthcare contract.
Completed the acquisition of Wincanton, expanding expertise in aerospace, industrials, and key geographies such as Germany.
Launched proprietary AI applications in warehouses, driving significant productivity improvements.
Invested 2.5% of sales in capex to drive growth.
Financial highlights
Full year 2024 revenue reached $11.7 billion, up 20% year over year, with 3% organic growth.
Q4 2024 revenue was $3.3 billion, up 25% year over year, with 4% organic growth.
Adjusted EBITDA for 2024 was $815 million, up 10%, with a margin of 7%.
Q4 adjusted EBITDA was $251 million, up 30% year over year; Q4 net income was $100 million.
Adjusted diluted EPS for 2024 was $2.80, up from $2.59 in 2023; full year net income was $138 million.
Outlook and guidance
2025 guidance: organic revenue growth of 3%-6%, adjusted EBITDA of $840-$860 million, and adjusted diluted EPS of $2.40-$2.60.
Adjusted EBITDA to free cash flow conversion expected at 25%-35%.
Sequential acceleration of organic growth expected throughout 2025, with Q1 impacted by customer capacity realignments.
Free cash flow conversion targeted at 30% of adjusted EBITDA for 2025.
Latest events from GXO Logistics
- Record revenue and new business wins drive strong 2026 outlook and margin expansion.GXO
Q4 202511 Feb 2026 - Q2 revenue up 19% to $2.85B, but net income down 41% amid acquisition and litigation costs.GXO
Q2 20242 Feb 2026 - Q3 revenue up 28% to $3.2B, strong pipeline, but net income down on higher costs.GXO
Q3 202416 Jan 2026 - 2024 saw record results, board refreshment, and a focus on ESG and pay-for-performance.GXO
Proxy Filing1 Dec 2025 - Q2 2025 revenue up 16%, guidance raised, Wincanton deal approved, CEO transition underway.GXO
Q2 202523 Nov 2025 - Q1 revenue up 21% to $3B, net loss $95M, guidance reaffirmed, and NHS contract boosts outlook.GXO
Q1 202519 Nov 2025 - Record Q3 revenue, 71% net income growth, and robust pipeline drive strong outlook.GXO
Q3 202513 Nov 2025